Javier Starkand

Consonance Capital Partners (CCP is a private equity manager focused exclusively on investing in the U.S. healthcare industry. CCP's founders, Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle, partnered together for over a decade while at JPMorgan Partners and its successor and predecessor entities, and have over 65 years of combined experience in private equity investing, primarily within healthcare. Consonance Capital Partners benefits from its association with Consonance Capital Management, a healthcare-focused manager founded in 2005 whose activity is investing in public equities. CCP targets growth equity, leveraged buyouts, and recapitalization transactions in the lower middle market. Target companies generally have between $20 million and $150 million in revenues. July 2014, Consonance announced the final closing of its $500 million healthcare private equity fund. The fund was oversubscribed, surpassing its $350 million target and reaching its fundraising cap of $500 million.